Home > Products > Active Pharmaceutical Ingredient
Cat. No. Product name CAS No.
DC8991 Molsidomine

Molsidomine is an orally active, long acting vasodilating drug, metabolized in the liver to the active metabolite linsidomine, which is an unstable compound that releases nitric oxide (NO) upon decay as the actual vasodilating compound.

25717-80-0
DCAPI1363 Mometasone furoate

Mometasone furoate

83919-23-7
DCAPI1006 Monobenzone (Benoquin)

Monobenzone (Benoquin)

103-16-2
DCAPI1331 Moxonidine

Moxonidine

75438-57-2
DCAPI1572 Moxonidine hydrochloride

Moxonidine hydrochloride

75536-04-8
DC9138 Mycophenolate Mofetil

Mycophenolate mofetil is a prodrug for mycophenolic acid, a potent inhibitor of inosine monophosphate dehydrogenase (IC50 = 11 nM). Inhibition of this enzyme blocks de novo GTP generation as well as RNA and DNA synthesis in lymphocytes. In this way, mycop

128794-94-5
DCAPI1127 Mycophenolic (Mycophenolate)

Mycophenolic (Mycophenolate)

24280-93-1
DC8980 Nabumetone

Nabumetone(BRL14777) is a non-steroidal anti-inflammatory drug and its active metabolite inhibits the COX.

42924-53-8
DCAPI1550 Naftopidil

Naftopidil is an α-1-Adrenergic receptor antagonist and an antihypertensive.

57149-07-2
DCAPI1173 Nalidixic acid (NegGram)

Nalidixic acid (NegGram)

389-08-2
DCAPI1293 Nanchangmycin

Nanchangmycin (dianemycin) is a polyether antibiotic with similar structure to dianemycin and is very active against a broad spectrum of harmful nematodes and insects but not for for mammals and plants.

65101-87-3
DCAPI1368 Naphyrone (O-2482)

Naphyrone (O-2482)

850352-53-3
DC9000 Naproxen sodium

Naproxen is a COX inhibitor for COX-1 and COX-2 with IC50 of 8.7 μM and 5.2 μM, respectively.

26159-34-2
DC8982 Naproxen

Naproxen is a COX inhibitor for COX-1 and COX-2 with IC50 of 8.7 μM and 5.2 μM, respectively.

22204-53-1
DCAPI1460 Naratriptan hydrochloride

Naratriptan Hydrochloride is a triptan drug which is used for the treatment of migraine headaches.

143388-64-1
DCAPI1337 Natamycin(Pimaricin)

Natamycin(Pimaricin)

7681-93-8
DC9063 Nateglinide

Nateglinide is an insulin secretagog agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM).

105816-04-4
DCAPI1056 Nattokinase Featured

Nattokinase, Natto fermentation is a potent fibrinolytic enzyme. Nattokinase can break down blood clots by directly hydrolyzing fibrin and plasmin substrate. Nattokinase can be used for the research of cardiovascular diseases.

133876-92-3
DCAPI1592 Nebivolol hydrochloride

Nebivolol hydrochloride is a highly selective β1-adrenoceptor antagonist

152520-56-4
DCAPI1393 Nedaplatin (Aqupla) Featured

Nedaplatin (Aqupla) is a derivative of cisplatin for inhibition of tumor colony forming units with IC50 of 28.5 μg/mL.

95734-82-0
DCAPI1574 Nefiracetam

Nefiracetam is a nootropic of the racetam family. Nefiracetam is cognitive enhancer with an IC50 of approximately 150–200 μM for Ro 5-4864. This compound activates L/N-type calcium channels, cholinergic, monoaminergic and GABAergic systems. Nefiracetam di

77191-36-7
DCAPI1513 Nefopan hydrochloride

Nefopanhydrochloride

23327-57-3
Page 18 / Total 32 FirstPrevNextLastGoto